SCHEMBL29409790

SCHEMBL29409790

C[C@]1(O)CC[C@@H]2C=COC(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]21

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HSP90AA1 P07900 8/20 0.45
▸ SYNJ2 O15056 2/20 0.44
▸ POLB P06746 1/20 0.43
▸ CTDSP1 Q9GZU7 1/20 0.43
▸ XDH P47989 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAPT P10636 1/20 0.37
▸ PTPN1 P18031 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9056347 1.00 L3MBTL1 (0.46) L3MBTL1HSP90AA1SYNJ2POLBCTDSP1
SCHEMBL29426036 0.82 L3MBTL1 (0.46) L3MBTL1HSP90AA1SYNJ2POLBCTDSP1
SCHEMBL29354606 0.81 HSP90AA1 (0.52) L3MBTL1HSP90AA1SYNJ2POLBCTDSP1
SCHEMBL4604126 0.81 HSP90AA1 (0.52) L3MBTL1HSP90AA1SYNJ2POLBCTDSP1
SCHEMBL29425844 0.78 HSP90AA1 (0.48) L3MBTL1HSP90AA1SYNJ2POLBCTDSP1
SCHEMBL29425841 0.78 POLB (0.46) HSP90AA1SYNJ2POLBCTDSP1MEN1
SCHEMBL30854808 0.77 L3MBTL1 (0.56) L3MBTL1HSP90AA1SYNJ2POLBCTDSP1
SCHEMBL422473 0.77 L3MBTL1 (0.56) L3MBTL1HSP90AA1SYNJ2POLBCTDSP1
SCHEMBL9058007 0.75 POLB (0.46) HSP90AA1SYNJ2POLBCTDSP1MEN1
SCHEMBL31345827 0.74 L3MBTL1 (0.50) L3MBTL1HSP90AA1SYNJ2POLBCTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598368-A1 COMPOSITION FOR INCREASING A COGNITIVE SKILL SFN Holding AG (CH) 2025-08-13 — — EP claimed
WO-2025012241-A1 COMPOSITION FOR INCREASING A COGNITIVE SKILL SFN HOLDING AG (CH) 2025-01-16 — — WO claimed
EP-4739127-A1 COMPOSITION FOR INCREASING A COGNITIVE SKILL SFN Holding AG (CH) 2026-05-13 — — EP disclosed
EP-4598368-A1 COMPOSITION FOR INCREASING A COGNITIVE SKILL SFN Holding AG (CH) 2025-08-13 — — EP disclosed
EP-4598368-A1 COMPOSITION FOR INCREASING A COGNITIVE SKILL SFN Holding AG (CH) 2025-08-13 — — EP disclosed
US-12296041-B2 Hair care compositions L'OREAL (FR) 2025-05-13 — — US disclosed
WO-2025071880-A1 COMPOSITIONS AND METHODS FOR IMPROVING THE SOLUBILITY OF IDEBENONE Villya LLC (US) 2025-04-03 — — WO disclosed
WO-2025012242-A1 COMPOSITION FOR INCREASING A COGNITIVE SKILL SFN HOLDING AG (CH) 2025-01-16 — — WO disclosed
WO-2025012241-A1 COMPOSITION FOR INCREASING A COGNITIVE SKILL SFN HOLDING AG (CH) 2025-01-16 — — WO disclosed
WO-2025012241-A1 COMPOSITION FOR INCREASING A COGNITIVE SKILL SFN HOLDING AG (CH) 2025-01-16 — — WO disclosed
EP-4424612-A1 DRY SHAMPOO SPRAY FOAM TECHNOLOGY Henkel AG & Co. KGaA (DE) 2024-09-04 — — EP disclosed
US-11414641-B2 Article and method for detecting aerobic bacteria 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-08-16 — — US disclosed
US-20220249508-A1 VARENICLINE COMPOUND AND PROCESS OF MANUFACTURE THEREOF WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT 2022-08-11 — — US disclosed
US-20220228185-A1 Recombinant Production of Steviol Glycosides EVOLVA SA (CH) 2022-07-21 — — US disclosed
EP-3993766-A1 PERSONAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2022-05-11 — — EP disclosed
EP-3450532-B1 USE OF AN AMODIMETHICONE/ORGANOSILICON-CONTAINING COPOLYMER, DETERGENT, USE OF THE DETERGENT AND WASHING METHOD HENKEL AG & CO KGAA (DE) 2022-05-04 — — EP disclosed
EP-3775131-B1 TEXTILE CARE PRODUCT HAVING OPTIONALLY CROSS-LINKED COPOLYMER AND METHOD FOR FINISHING TEXTILES HENKEL AG & CO KGAA (DE) 2022-03-23 — — EP disclosed
EP-3775128-B1 TEXTILE CARE PRODUCT HAVING OPTIONALLY CROSS-LINKED COPOLYMER AND METHOD FOR FINISHING TEXTILES HENKEL AG & CO KGAA (DE) 2022-03-23 — — EP disclosed
EP-3775129-B1 TEXTILE CARE PRODUCT HAVING OPTIONALLY CROSS-LINKED COPOLYMER AND METHOD FOR FINISHING TEXTILES HENKEL AG & CO KGAA (DE) 2022-03-23 — — EP disclosed
EP-3775130-B1 TEXTILE CARE PRODUCT HAVING OPTIONALLY CROSS-LINKED COPOLYMER AND METHOD FOR FINISHING TEXTILES HENKEL AG & CO KGAA (DE) 2022-03-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12296041-B2 Hair care compositions SGMS1, PHOSPHO1, EP300 L3MBTL1 3788/4885HSP90AA1 654/4885SYNJ2 4220/4885
US-20220249508-A1 VARENICLINE COMPOUND AND PROCESS OF MANUFACTURE THEREOF COMT, CYP2C9, CYP3A7 L3MBTL1 4201/4885HSP90AA1 4830/4885SYNJ2 2210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback